Applied DNA Sciences Stock to Reverse Split on Thursday, April 25th (NASDAQ:APDN)

Shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) are scheduled to reverse split on Thursday, April 25th. The 1-20 reverse split was announced on Thursday, April 25th. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, April 25th.

Applied DNA Sciences Stock Performance

Shares of NASDAQ APDN traded down $0.04 during trading on Tuesday, hitting $0.29. The stock had a trading volume of 811,420 shares, compared to its average volume of 116,854. Applied DNA Sciences has a 12 month low of $0.28 and a 12 month high of $1.86. The firm has a fifty day moving average of $0.49 and a two-hundred day moving average of $0.67.

Applied DNA Sciences (NASDAQ:APDN) last announced its quarterly earnings results on Thursday, February 8th. The technology company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.31) by $0.22. The firm had revenue of $0.89 million for the quarter, compared to analysts’ expectations of $0.70 million. Applied DNA Sciences had a negative return on equity of 159.93% and a negative net margin of 80.14%. As a group, equities research analysts predict that Applied DNA Sciences will post -0.63 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have commented on APDN. StockNews.com began coverage on shares of Applied DNA Sciences in a research report on Sunday. They set a “hold” rating on the stock. HC Wainwright dropped their price target on Applied DNA Sciences from $2.00 to $1.50 and set a “buy” rating for the company in a research note on Friday, February 9th.

Hedge Funds Weigh In On Applied DNA Sciences

An institutional investor recently bought a new position in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC bought a new position in Applied DNA Sciences, Inc. (NASDAQ:APDN) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned approximately 0.72% of Applied DNA Sciences at the end of the most recent quarter. 22.22% of the stock is owned by institutional investors.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.